Product Document Searching Made Easy by 2D Code! | TCI Chemistry News June 2026 | [TCIPracticalExample] Oxidation Reaction of Heterocycles Using... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 106266-06-2 | Product Number: R0087
Risperidone
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 50MG |
$79.00
|
≥40 | 35 | It can be shipped in about 2 weeks after ordering | |
| 500MG |
$368.00
|
13 | 0 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | R0087 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__3H__2__7FN__4O__2 = 410.49 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container
|
500MG-Glass Bottle with Plastic Insert (View image), 50MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 106266-06-2 |
| Reaxys Registry Number | 4891881 |
| PubChem Substance ID | 125307687 |
| Merck Index (14) | 8233 |
| MDL Number | MFCD00274576 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 170.0 to 174.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 172 °C |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | UV1164800 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2934.99-000 |
Application
Risperidone: A Dopamine D2 and Serotonin 5-HT2 Receptors Antagonist
Risperidone, a benzisoxazole derivative, acts as a dopamine type 2 (D2) and serotonin type 2 (5-HT2) receptors antagonist. In addition, risperidone has affinity for α1- and α2-adrenergic, and H1 histaminergic receptors. While, risperidone has low to moderate affinity for the serotonin 5-HT1C, 5-HT1D and 5-HT1A receptors, week affinity for the dopamine D1 and haloperidol-sensitive sigma binding site, and no affinity for cholinergic muscarinic or β1 and β2 adrenergic receptors. Its major active metabolite is paliperidone (9-hydroxyrisperidone) [P1897]. Risperidone is used as a long acting antipsychotic agent with relatively few side effects. (The product is for research purpose only.)
References
- Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties
- Biochemical profile of risperidone, a new antipsychotic
- Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
- Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
- Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4
- The pharmacokinetics of paliperidone versus risperidone (a review)
- Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry
Application
HDAC2 may be a New Target for Schizophrenia Treatment
Reference
- HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
PubMed Literature
Documents
Product Documents (Note: Some products will not have analytical charts available.)
Enter TCI Product Number
Enter KISHIDA Product Number
4-5 alphanumeric characters before the hyphen
7 alphanumeric characters
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
• The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
• Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
• If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
• Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Incorrect Lot Number. Please input only the 7 alphanumeric characters.
The requested analytical chart is not available. Sorry for the inconvenience.